Most frequent first cART regimens stratified by menopausal status at the initiation of antiretroviral therapy (baseline).
- Guilherme Amaral Calvet (525229)
- Luciane Velasque (353931)
- Paula Mendes Luz (353930)
- Sandra Wagner Cardoso (525230)
- Monica Derrico (525231)
- Ronaldo Ismério Moreira (525232)
- Angela Cristina Vasconcelos de Andrade (353929)
- Andrea Cytryn (525233)
- Elaine Pires (353934)
- Valdiléa Gonçalves Veloso (353932)
- Beatriz Grinsztejn (116216)
- Ruth Khalili Friedman (353935)
Publication date
February 2014
DOIAbstract
<p>3TC, lamivudine; ATV/r, atazanavir/ritonavir; d4T, stavudine; ddI, didanosine; EFV, efavirenz;</p><p>FTC, emtricitabine; IDV/r, indinavir/ritonavir; LOP/r, lopinavir/ritonavir; SQV/r, saquinavir/ritonavir;</p><p>NFV, nelfinavir; TDF, tenofovir; ZDV, zidovudine;</p><p>cART: combination antiretroviral therapy; PI: Protease inhibitor;</p><p>NNRTI: Non-Nucleoside Reverse Transcriptase Inhibitors.</p
Add to ORKG